Stock BALPHARMA BAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Bal Pharma Limited NSE India S.E.

Equities

BALPHARMA

INE083D01012

Market Closed - NSE India S.E.
Other stock markets
 07:40:47 2024-04-29 am EDT 		5-day change 1st Jan Change
100.4 INR +0.15% Intraday chart for Bal Pharma Limited +2.81% +0.40%
Feb. 12 Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acuite Keeps BBB- Rating on Bal Pharma's Bank Loans; Outlook Stable
MT
Acuite Upgrades Rating on Bal Pharma's Fund-Based Financing to BBB-; Lowers Outlook to Stable
MT
ICRA Maintains BB+ Rating on Bal Pharma's Long-Term Bank Financing; Raises Outlook to Positive
MT
Bal Pharma : ICRA Raises Rating on Bal Pharma's Fund-Based Financing, Term Loan to BB+; Keeps Stable Outlook
MT
Bal Pharma : ICRA Reaffirms Bal Pharma's Fund-Based Facilities BB Rating; Raises Outlook to Stable
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BALPHARMA Stock
  4. BALPHARMA Stock
  5. News Bal Pharma Limited
  6. Analyst Reco.